WALDEN UNIVERSITY • NRNP 6665 • PSYCHIATRIC-MENTAL HEALTH NURSE PRACTITIONER
Week 6 Midterm Exam
Questions and Answers — 155 Verified Items
Latest Update • Verified Answers
EXAM VOLUME SECTIONS COGNITIVE MIX
25% Recall / 55% Apply / 20%
155 Questions 9 Competency Areas
Analyze
EXAM SCOPE & ALIGNMENT
Aligned with: Walden University NRNP 6665 Week 6 midterm exam blueprint; PMHNP competencies (AACN
Essentials, NONPF); DSM-5-TR diagnostic criteria; current FDA approvals and black box warnings;
evidence-based prescribing guidelines.
Content domains: PMHNP role/scope/ethics; psychiatric assessment and DSM-5-TR diagnostic reasoning;
neurobiology and psychopharmacology; depressive disorders and antidepressants; bipolar and mood stabilizers;
anxiety, OCD, and trauma; schizophrenia spectrum and antipsychotics; substance use disorders and MAT;
psychotherapy, crisis intervention, and Week 6 integration.
Question style: 75% scenario-based medication selection, adverse-effect recognition, drug interaction
identification, and psychiatric emergency management; 25% direct recall of diagnostic criteria, drug classifications,
and treatment guidelines. All distractors derived from common PMHNP errors.
Verification: Each correct answer is verified against current PMHNP standards, DSM-5-TR criteria, and FDA
prescribing information including black box warnings (e.g., clozapine REMS, antidepressant suicidality warning,
lamotrigine SJS/TEN, valproate teratogenicity).
Designed for: NRNP 6665 Week 6 midterm preparation; PMHNP certification exam readiness; high-confidence
clinical decision-making in advanced practice psychiatric-mental health nursing.
,NRNP 6665 • Psychiatric-Mental Health Nurse Practitioner • Week 6 Midterm Latest 2026/2027 • Verified Answers
Aligned with AACN Essentials, NONPF Core Competencies, DSM-5-TR, and current FDA prescribing
guidelines
Aligned with PMHNP competencies and DSM-5-TR Page 2
,NRNP 6665 • Psychiatric-Mental Health Nurse Practitioner • Week 6 Midterm Latest 2026/2027 • Verified Answers
Exam Blueprint & Competency Map
# Section Question Range Items
1 Section 1: Foundations of PMHNP Practice Q1 – Q14 14
Section 2: Psychiatric Assessment and Diagnostic
2 Q15 – Q30 16
Reasoning
Section 3: Neurobiology and Psychopharmacology
3 Q31 – Q46 16
Foundations
Section 4: Depressive Disorders and Antidepressant
4 Q47 – Q68 22
Pharmacology
5 Section 5: Bipolar and Related Disorders Q69 – Q84 16
Section 6: Anxiety, OCD, and Trauma-Related
6 Q85 – Q104 20
Disorders
Section 7: Schizophrenia Spectrum and Antipsychotic
7 Q105 – Q124 20
Pharmacology
Section 8: Substance Use Disorders and Withdrawal
8 Q125 – Q140 16
Management
Section 9: Psychotherapy, Crisis Intervention, and
9 Q141 – Q155 15
Week 6 Integration
— TOTAL Q1 – Q155 155
Cognitive Level Distribution
Recall (Criteria / Mechanisms / ~25% Direct recall of DSM-5-TR criteria, drug
Guidelines) mechanisms, receptor subtypes, monitoring
parameters, and treatment guidelines
Application (Scenario-based) ~55% Medication selection by patient profile, adverse
effect recognition, monitoring parameter
interpretation, drug interaction identification,
special population prescribing
Aligned with PMHNP competencies and DSM-5-TR Page 3
, NRNP 6665 • Psychiatric-Mental Health Nurse Practitioner • Week 6 Midterm Latest 2026/2027 • Verified Answers
Analysis (Differentiation) ~20% Differentiating NMS vs. serotonin syndrome,
bipolar I vs. II, MDD vs. bipolar depression,
capacity vs. competency, Alzheimer's vs. Lewy
body dementia
How to Read Each Test Card
Each card follows a uniform structure to support rapid review and spaced repetition:
• Stem: A concise question, often a clinical scenario requiring integration of assessment, diagnosis, and
treatment planning.
• Options A–D: Four choices; one is verified correct and three are plausible distractors drawn from common
PMHNP errors (e.g., misapplying DSM-5-TR criteria, confusing similar diagnoses, missing black box
warnings, misidentifying NMS vs. serotonin syndrome).
• Correct Answer: The verified letter (e.g., “C”) and the option text, marked [CORRECT].
• Rationale: 2–4 sentences explaining why the correct answer is right and why distractors are wrong, including
DSM-5-TR criteria, neurobiological mechanisms, pharmacological principles, clinical guidelines, and safety
considerations.
Aligned with PMHNP competencies and DSM-5-TR Page 4
Week 6 Midterm Exam
Questions and Answers — 155 Verified Items
Latest Update • Verified Answers
EXAM VOLUME SECTIONS COGNITIVE MIX
25% Recall / 55% Apply / 20%
155 Questions 9 Competency Areas
Analyze
EXAM SCOPE & ALIGNMENT
Aligned with: Walden University NRNP 6665 Week 6 midterm exam blueprint; PMHNP competencies (AACN
Essentials, NONPF); DSM-5-TR diagnostic criteria; current FDA approvals and black box warnings;
evidence-based prescribing guidelines.
Content domains: PMHNP role/scope/ethics; psychiatric assessment and DSM-5-TR diagnostic reasoning;
neurobiology and psychopharmacology; depressive disorders and antidepressants; bipolar and mood stabilizers;
anxiety, OCD, and trauma; schizophrenia spectrum and antipsychotics; substance use disorders and MAT;
psychotherapy, crisis intervention, and Week 6 integration.
Question style: 75% scenario-based medication selection, adverse-effect recognition, drug interaction
identification, and psychiatric emergency management; 25% direct recall of diagnostic criteria, drug classifications,
and treatment guidelines. All distractors derived from common PMHNP errors.
Verification: Each correct answer is verified against current PMHNP standards, DSM-5-TR criteria, and FDA
prescribing information including black box warnings (e.g., clozapine REMS, antidepressant suicidality warning,
lamotrigine SJS/TEN, valproate teratogenicity).
Designed for: NRNP 6665 Week 6 midterm preparation; PMHNP certification exam readiness; high-confidence
clinical decision-making in advanced practice psychiatric-mental health nursing.
,NRNP 6665 • Psychiatric-Mental Health Nurse Practitioner • Week 6 Midterm Latest 2026/2027 • Verified Answers
Aligned with AACN Essentials, NONPF Core Competencies, DSM-5-TR, and current FDA prescribing
guidelines
Aligned with PMHNP competencies and DSM-5-TR Page 2
,NRNP 6665 • Psychiatric-Mental Health Nurse Practitioner • Week 6 Midterm Latest 2026/2027 • Verified Answers
Exam Blueprint & Competency Map
# Section Question Range Items
1 Section 1: Foundations of PMHNP Practice Q1 – Q14 14
Section 2: Psychiatric Assessment and Diagnostic
2 Q15 – Q30 16
Reasoning
Section 3: Neurobiology and Psychopharmacology
3 Q31 – Q46 16
Foundations
Section 4: Depressive Disorders and Antidepressant
4 Q47 – Q68 22
Pharmacology
5 Section 5: Bipolar and Related Disorders Q69 – Q84 16
Section 6: Anxiety, OCD, and Trauma-Related
6 Q85 – Q104 20
Disorders
Section 7: Schizophrenia Spectrum and Antipsychotic
7 Q105 – Q124 20
Pharmacology
Section 8: Substance Use Disorders and Withdrawal
8 Q125 – Q140 16
Management
Section 9: Psychotherapy, Crisis Intervention, and
9 Q141 – Q155 15
Week 6 Integration
— TOTAL Q1 – Q155 155
Cognitive Level Distribution
Recall (Criteria / Mechanisms / ~25% Direct recall of DSM-5-TR criteria, drug
Guidelines) mechanisms, receptor subtypes, monitoring
parameters, and treatment guidelines
Application (Scenario-based) ~55% Medication selection by patient profile, adverse
effect recognition, monitoring parameter
interpretation, drug interaction identification,
special population prescribing
Aligned with PMHNP competencies and DSM-5-TR Page 3
, NRNP 6665 • Psychiatric-Mental Health Nurse Practitioner • Week 6 Midterm Latest 2026/2027 • Verified Answers
Analysis (Differentiation) ~20% Differentiating NMS vs. serotonin syndrome,
bipolar I vs. II, MDD vs. bipolar depression,
capacity vs. competency, Alzheimer's vs. Lewy
body dementia
How to Read Each Test Card
Each card follows a uniform structure to support rapid review and spaced repetition:
• Stem: A concise question, often a clinical scenario requiring integration of assessment, diagnosis, and
treatment planning.
• Options A–D: Four choices; one is verified correct and three are plausible distractors drawn from common
PMHNP errors (e.g., misapplying DSM-5-TR criteria, confusing similar diagnoses, missing black box
warnings, misidentifying NMS vs. serotonin syndrome).
• Correct Answer: The verified letter (e.g., “C”) and the option text, marked [CORRECT].
• Rationale: 2–4 sentences explaining why the correct answer is right and why distractors are wrong, including
DSM-5-TR criteria, neurobiological mechanisms, pharmacological principles, clinical guidelines, and safety
considerations.
Aligned with PMHNP competencies and DSM-5-TR Page 4
